Citadel Advisors’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $6.71M | Buy |
|
|||||
2025
Q1 | $4.52M | Buy |
|
|||||
2024
Q4 | $5.21M | Buy |
|
|||||
2024
Q3 | $6.56M | Sell |
|
|||||
2024
Q2 | $10.5M | Buy |
|
|||||
2024
Q1 | $2.97M | Sell |
|
|||||
2023
Q4 | $7.19M | Sell |
|
|||||
2023
Q3 | $5.92M | Sell |
|
|||||
2023
Q2 | $10.2M | Buy |
|
|||||
2023
Q1 | $1.18M | Sell |
|
|||||
2022
Q4 | $1.19M | Sell |
|
|||||
2022
Q3 | $4.92M | Buy |
|
|||||
2022
Q2 | $1.44M | Sell |
|
|||||
2022
Q1 | $8.54M | Buy |
|
|||||
2021
Q4 | $4.97M | Buy |
|
|||||
2021
Q3 | – | Sell |
|
|||||
2021
Q2 | $492K | Sell |
|
|||||
2021
Q1 | $722K | Sell |
|
|||||
2020
Q4 | $1.41M | Buy |
|
|||||
2020
Q3 | $1.01M | Buy |
|
|||||
2020
Q2 | $848K | Sell |
|
|||||
2020
Q1 | $1.28M | Buy |
|
|||||
2019
Q4 | – | Sell |
|
|||||
2019
Q3 | $2.62M | Buy |
|
|||||
2019
Q2 | $1.21M | Buy |
|
|||||
2019
Q1 | $289K | Sell |
|
|||||
2018
Q4 | $637K | Buy |
|
|||||
2018
Q2 | – | Sell |
|
|||||
2018
Q1 | $641K | Buy |
|
|||||
2017
Q3 | – | Sell |
|
|||||
2017
Q2 | $1.65M | Sell |
|
|||||
2017
Q1 | $5.16M | Buy |
|
|||||
2016
Q4 | $341K | Sell |
|
|||||
2016
Q3 | $1.25M | Sell |
|
|||||
2016
Q2 | $3.47M | Buy |
|
|||||
2016
Q1 | $148K | Buy |
|
|||||
2015
Q4 | $147K | Buy |
|
|||||
2015
Q3 | – | Sell |
|
|||||
2015
Q2 | $1.29M | Buy |
|
|||||
2015
Q1 | $870K | Buy |
|
|||||
2014
Q4 | $585K | Buy |
|
|||||
2014
Q3 | $183K | Buy |
|